NCT02633891

Brief Summary

Obesity and the metabolic syndrome (MetS) are rapidly growing problems. Individuals with the MetS are at risk for not only future chronic diseases, but they have a higher prevalence of neuropathy, including cardiac autonomic neuropathy, and have a higher incidence of falls. Currently there are no effective therapies to prevent or reverse the neuropathy seen in the MetS or to reduced the fall risk in this population. This research project will determine if a tailored balance exercise program will have functional benefits and result in a reduced fall risk in the growing population of patients with the MetS and neuropathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 17, 2015

Completed
1 year until next milestone

Study Start

First participant enrolled

January 2, 2017

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2022

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

June 28, 2024

Completed
Last Updated

June 28, 2024

Status Verified

March 1, 2024

Enrollment Period

5.2 years

First QC Date

December 15, 2015

Results QC Date

May 9, 2023

Last Update Submit

March 6, 2024

Conditions

Keywords

neuropathiesmetabolic diseasesnervous system diseasesperipheral nervous system diseases

Outcome Measures

Primary Outcomes (1)

  • Four Square Step Test (FSST)

    A measure of proactive dynamic standing balance. A participant steps over four canes that are laid on the ground at 90 degree angles to each other. The participants stands in one of the squares formed by the canes and they are instructed to step as quickly as possible into each square in a specified sequence.

    12 weeks

Secondary Outcomes (1)

  • Dynamic Gait Index (DGI)

    12 weeks

Study Arms (2)

Balance exercise program

EXPERIMENTAL

Participants will attend weekly group training sessions and will keep an exercise log of home activity during a three month exercise program designed to improve balance. Balance exercises will be performed three times per week in a home-based training program.

Behavioral: Balance exercise

standard care

ACTIVE COMPARATOR

Participants will meet in person on a weekly basis for a general education class regarding health and fall prevention but will not participate in an exercise class.

Behavioral: Standard care

Interventions

tailored balance exercise program

Balance exercise program
Standard careBEHAVIORAL

general health education and fall prevention classes

standard care

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • MetS at the time of screening based on the International Diabetes Federation definition
  • No risk factors for other causes of neuropathy
  • Autonomic neuropathy as defined by the Toronto Diabetic Neuropathy Expert Group 2010/11 consensus criteria
  • Age 45-75 years inclusive at the time of screening
  • Medically stable at the time of enrollment
  • Able to participate in a standing balance exercise program without constant standby monitoring
  • Women of childbearing potential must be using an acceptable method of contraception for the duration of their participation in the study
  • Willing to accept assignment to either training group
  • Willing and able to participate in the assigned intervention program

You may not qualify if:

  • Pregnant women, prisoners, institutionalized subjects and other at risk subjects
  • Etiology of neuropathy other than the MetS
  • History of severe medical conditions likely to shorten lifespan or alter ability to participate in the trial
  • Severe autonomic neuropathy that restricts daily function and the ability to participate in study interventions
  • An inability to understand or cooperate with the procedures of the trial or refusal to sign the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

Metabolic SyndromeMetabolic DiseasesNervous System DiseasesPeripheral Nervous System Diseases

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersNutritional and Metabolic DiseasesNeuromuscular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Dr. Lindsay Zilliox
Organization
BVAMC

Study Officials

  • Lindsay A Zilliox, MD

    Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
single blind
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: parallel treatments
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2015

First Posted

December 17, 2015

Study Start

January 2, 2017

Primary Completion

March 28, 2022

Study Completion

March 28, 2022

Last Updated

June 28, 2024

Results First Posted

June 28, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations